About: Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 2007 (uk) artículu científicu espublizáu en xunetu de 2007 (ast) scientific article published on 01 July 2007 (en)
publication date	wds:Q80548343-BB90A643-C271-4309-B770-AAF53D18BC39
publication date	2007-07-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q80548343-0D96E690-F951-4323-934C-AA4C0FF4593D wds:Q80548343-17CA20CC-976F-4F05-B074-133426FB0EF6 wds:Q80548343-233F4134-9C44-44BD-8A4F-41A119221C86 wds:Q80548343-27EE822E-37DC-4D76-A02A-15F2DA050D43 wds:Q80548343-8E286056-5444-45EB-BD71-287B6DCC0157 wds:Q80548343-900E09D4-231E-4EF3-B279-D869F077CF2E wds:Q80548343-A54B4D32-1636-4942-94CB-31C1A4E8B88D wds:Q80548343-B1D48321-672E-4E47-99E2-9BC34632B22D wds:Q80548343-BE60323A-7099-468B-8720-8CF182253B4E wds:Q80548343-CB4EB47A-A565-403B-89AD-B42EABEB3863 wds:Q80548343-DA2899C4-DB5C-4F1E-82FE-49C5CAB34EE3 wds:Q80548343-DB336A62-13B8-4FD5-BCF6-64A3BA039D26 wds:Q80548343-F6A2B57B-3220-4A4F-96A0-F17FC1A5A67E
author name string	Paul Cordopatis Dimitris Mavroudis Vassilis Georgoulias Kostas Kosmatopoulos Athanassios Kotsakis Charalambos Christophylakis Despoina Aggouraki Irini Bolonaki Irini Nikoloudi Elsa Papadimitraki Aphrodite Vagia Elefterios Magganas George Konsolakis
rdfs:label	Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide (en) Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide (nl)
skos:prefLabel	Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide (en) Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide (nl)
name	Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide (en) Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide (nl)
author	wds:Q80548343-8F55D110-6AF0-409C-8E35-2629173D98A6
author	Athanassios S Galanis
title	wds:Q80548343-B146EDBC-4142-42F8-B2E9-0B2C5D3FDFF8
title	Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide (en)
page(s)	wds:Q80548343-0DFB2C57-AFF3-48C3-8747-E7E7326E08F0
page(s)	2727-2734
instance of	wds:Q80548343-DAE18419-3330-45FD-A7D0-575B8594FA0E
instance of	scholarly article
main subject	wds:Q80548343-355DBECD-2617-4275-AA46-1CACCD6D4836
main subject	lung cancer
PubMed ID	wds:Q80548343-668AEA39-D805-4DBB-ACBD-81DDF7A3FE7D
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17602077
PubMed ID	17602077
published in	wds:Q80548343-E56C40C7-2299-4397-B857-638A801A34E6
published in	Journal of Clinical Oncology
issue	wds:Q80548343-78E0D7BC-556A-4405-BF68-1BD0E8EDA4DD
volume	wds:Q80548343-429DD2A0-F134-46E1-8EC8-47E942D2F125
issue	19
volume	25
DOI	wds:Q80548343-2EC4630D-15E6-4D7F-82A3-F2FFB9130264
DOI	http://dx.doi.org/10.1200/JCO.2006.10.3465
DOI	10.1200/JCO.2006.10.3465
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80548343
is cites work of	Therapeutic cancer vaccines: are we there yet? Therapeutic Targeting of Telomerase A second chance for telomerase reverse transcriptase in anticancer immunotherapy Trial Watch: Peptide vaccines in cancer therapy Myeloid dendritic cells loaded with dendritic tandem multiple antigenic telomerase reverse transcriptase (hTERT) epitope peptides: a potentially promising tumor vaccine. The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation Telomerase and cancer therapeutics Immunotherapy as a strategy for the treatment of non-small-cell lung cancer RFPL3 and CBP synergistically upregulate hTERT activity and promote lung cancer growth New targets for the immunotherapy of colon cancer-does reactive disease hold the answer? Shortcomings of current therapies for non-small-cell lung cancer: unmet medical needs Immunogenicity of a recombinant lentiviral vector carrying human telomerase tumor antigen in HLA-B*0702 transgenic mice Lung cancer: potential targets for immunotherapy Antigen-based therapy for the treatment of type 1 diabetes Prospects and challenges of building a cancer vaccine targeting telomerase Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer Telomere and Telomerase Therapeutics in Cancer Naturally occurring tumor-specific CD8+ T-cell precursors in individuals with and without cancer Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines Upregulated human telomerase reverse transcriptase (hTERT) expression is associated with spinal chordoma growth, invasion and poor prognosis Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer. Telomerase based anticancer immunotherapy and vaccines approaches. Epstein-Barr virus and telomerase: from cell immortalization to therapy Telomerase and the endocrine system TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens Telomerase-Targeted Cancer Immunotherapy In vitro activation of hTERT-specific T cell responses in lung cancer patients following chemotherapy Efficient induction of cytotoxic T lymphocytes in hepatocellular carcinoma using the HLA-A2-restricted survivin peptide in vitro Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial
is cites work of	wds:Q26741736-CED65A99-1BAA-42FD-94E1-8287B5ACEFF7 wds:Q34044752-FAE9AAFA-C68E-4CD3-AB67-1EEFA7C6F11D wds:Q39676680-6836436A-FD22-4316-97B2-1A0289A7895F wds:Q41878129-897E9001-3B4D-4030-966C-8CF0377A1786 wds:Q53175501-9649D185-E9C6-4873-B5AB-665FD19D81EA wds:Q82835695-E45DD539-4F31-4BA5-9305-1833FEB10B95 wds:Q34786691-914F941A-1141-40AA-ACCC-9BAE62C90D74 wds:Q42734544-02D35440-F7E3-4C0A-A28D-5AEBBBF9BBE1

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software